The drug ivacaftor appears to be safe for children 2 to 5 years old with specific types of a cystic fibrosis…
Articles by Daniela Semedo, PhD
A recent study in the American Journal of Critical Care Medicine suggested a new therapeutic target for…
Keiser University has raised $50,000 to support the Cystic Fibrosis Foundation through the efforts of its staff and students across 17 campuses in Florida. This…
A team of specialists in the United Kingdom are investigating whether a novel hearing test could effectively detect early hearing…
Contrary to previous research, in a recent study published in the journal BMC Pulmonary Medicine, scientists did not…
Galapagos NV, a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes…
Proteostasis Therapeutics, Inc. (PTI), a company that develops disease-modifying therapeutics for diseases involving protein processing, recently announced at a presentation during…
Alcresta, a company dedicated to developing and commercializing novel enzyme-based products that address the challenges faced by patients with gastrointestinal disorders…
The European Medicines Agency (EMA) recently announced that it has validated the submission of a new indication for Translarna…
Vertex Pharmaceuticals, a global biotechnology company developing and commercializing innovative therapies for diseases such as cystic fibrosis, recently announced that the…